Medical expert of the article
New publications
How is anthrax treated?
Last reviewed: 23.04.2024
All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.
We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.
If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.
Mode - bed rest before temperature normalization. Diet - table number 13, in severe cases - enteral-parenteral nutrition. Treatment of anthrax includes etiotropic and pathogenetic therapy, carried out depending on the form of the disease and available clinical and laboratory syndromes. Etiotropic treatment of anthrax is presented in the treatment regimens of various forms of the disease.
Scheme of the use of antibacterial drugs for the treatment of anthrax (dermal form with a light course)
A drug |
Mode of application |
Single dose, g |
Multiplicity of application in days |
Duration of the course, day |
Ampicillin |
Inside |
0.5 |
4 |
7th |
Doxycycline |
Inside |
0.2 |
2 |
7th |
Rifampicin |
Inside |
0.45 |
2 |
7th |
Pefloxacin |
Inside |
0.4 |
2 |
7th |
Ofloxacin |
Inside |
0.2 |
3 |
7th |
Ciprofloxacin |
Inside |
0.25-0.75 |
2 |
7th |
Benzylpenicillin |
In / m |
1 million units |
4 |
7th |
Gentamicin |
In / m |
0.08 |
3 |
7th |
Amikacin |
In / m |
0.5 |
2 |
7th |
Levomycetin sodium succinate |
In / in |
70-100 mg / kg |
1 |
7th |
Scheme of antibacterial drugs in the treatment of anthrax (severe course)
A drug |
Mode of application |
Single dose, g |
Multiplicity of application per day |
Duration of the course, day |
Benzylpenicillin |
V / m, in / in |
1 million units |
6th |
14-21 |
Ampicillin |
In / m |
2-3 |
4 |
14 |
Rifampicin |
V / m, in / in |
0.3 |
2 |
14-21 |
Doxycycline |
In / in |
0.2 |
2 |
10-14 |
Gentamicin |
V / m, in / in |
0.16 |
2-3 |
10 |
Amikacin |
V / m, in / in |
0.5 |
2 |
10 |
Ciprofloxacin |
In / in |
0.2 |
2 |
10 |
Pefloxacin |
In / in |
0.4 |
2 |
10 |
Rifampicin Ampicillin |
V / m, in / in In / in |
0.45 2 |
1 4 |
14 14 |
Rifampicin + Doxycycline |
V / m, in / in In / in |
0.45 0.2 |
1 1 |
14 14 |
Schemes for the use of antibacterial drugs in the treatment of an inhalation form of anthrax in cases of acts of biological terrorism
Victim categories |
Initial therapy (intravenous administration) |
Duration of the course, day |
Adults |
Ciprofloxacin 500 mg every 12 hours or doxycycline 100 mg every 12 hours and one or two additional antimicrobials |
Begin with intravenous administration, then intake, depending on the clinical course: ciprofloxacin 500 mg twice a day or doxycycline 100 mg twice a day. Duration 6 days |
Children | Every 12 hours ciprofloxacin at a dose of 10-15 mg / kg body weight or doxycycline: |
Begin with intravenous administration, then ingestion every 12 hours, depending on the clinical course: ciprofloxacin at a dose of 10-15 mg / kg body weight or doxycycline: |
at the age of over 8 years with a body weight of more than 45 kg | for 100 mg | for 100 mg |
aged over 8 years with a body weight of 45 kg and less | at 2.2 mg / kg | at 2.2 mg / kg |
At the age of 8 years and younger |
At 2.2 mg / kg - 1-2 additional antimicrobial preparations |
At 2.2 mg / kg Duration 6 days |
Pregnant |
The same. As for the rest of adults, High mortality exceeds the risk of complications of antibiotic therapy |
Begin with intravenous administration, then intake, depending on the clinical course: the schemes are the same as for the remaining adults |
Persons with immunodeficiency states |
Same as for adults and children without immunodeficiency |
Same as for adults and children without immunodeficiency |
Scheme of antibacterial drugs in the treatment of cutaneous anthrax in cases of acts of biological terrorism
Victim categories |
Initial therapy (ingestion) |
Duration of the course, day |
Adults |
Ciprofloxacin 500 mg twice daily or doxycycline 100 mg twice daily |
6th |
Children | Ciprofloxacin 10-15 mg kg body weight every 12 hours or doxycycline every 12 hours. |
6th |
at the age of over 8 years with a body weight of more than 45 kg | for 100 mg | |
aged over 8 years with a body weight of 45 kg and less | at 2.2 mg / kg | |
At the age of 8 years and younger |
At 2.2 mg / kg | |
Pregnant |
Ciprofloxacin 500 mg twice daily or doxycycline 100 mg twice daily |
6 days |
Persons with immunodeficiency states |
The same. As for adults and children without immunodeficiency |
6 days |
Etiotropic treatment of anthrax should be combined with a single administration of a specific anti-STI immunoglobulin at a dose of 20-100 ml intramuscularly (the dose depends on the severity of the condition). Local therapy consists only in the treatment of affected skin with solutions of antiseptics. Bandages do not impose. Surgical intervention is contraindicated because it promotes generalization of the infection. With the development of infectious-toxic shock, widespread edema of the face and neck, it is recommended to administer prednisolone in a dose of 90-240 mg. According to individual indications, detoxification therapy is carried out. In the generalized form of the disease, antibiotic therapy is combined with intensive detoxification, measures aimed at combating hemodynamic disorders. Intravenous perfusion of polyionic solutions is used in the volume necessary to restore the volume of circulating blood, microcirculation, water-electrolyte balance (2-5 L), daily with the addition of 100 ml of polyglucin, rheopolyglucin or gemodeza. Oxygenotherapy, hyperbaric oxygenation, extracorporeal detoxification methods are used.
Approximate terms of incapacity for work
The recovery of patients recovering from the skin form of anthrax is carried out after the removal of the scab and formation of a scar. Patients who have transferred generalized forms of the disease are discharged after complete clinical recovery and a twofold negative result of bacteriological studies conducted at intervals of 5 days. Examination is not regulated.